Free Trial
NASDAQ:TBIO

Telesis Bio (TBIO) Stock Price, News & Analysis

Telesis Bio logo
$0.30 0.00 (0.00%)
As of 07/3/2025

About Telesis Bio Stock (NASDAQ:TBIO)

Key Stats

Today's Range
$0.30
$0.30
50-Day Range
$0.01
$0.90
52-Week Range
$0.01
$6.17
Volume
N/A
Average Volume
6,759 shs
Market Capitalization
$540.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Telesis Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

TBIO MarketRank™: 

Telesis Bio scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Telesis Bio.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Telesis Bio is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Telesis Bio is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Telesis Bio has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Telesis Bio's valuation and earnings.
  • Percentage of Shares Shorted

    0.18% of the float of Telesis Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Telesis Bio has a short interest ratio ("days to cover") of 25, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Telesis Bio has recently decreased by 13.79%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Telesis Bio does not currently pay a dividend.

  • Dividend Growth

    Telesis Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.18% of the float of Telesis Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Telesis Bio has a short interest ratio ("days to cover") of 25, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Telesis Bio has recently decreased by 13.79%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Telesis Bio this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Telesis Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    24.50% of the stock of Telesis Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 37.63% of the stock of Telesis Bio is held by institutions.

  • Read more about Telesis Bio's insider trading history.
Receive TBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter.

TBIO Stock News Headlines

Have you heard of “E.I.”?
Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing to invest in new "E.I." Tech, which one expert estimates will grow by 200,000%. Becoming bigger than the automobile, PC, and cell phone markets... COMBINED!
Telesis Bio Announces Departure of Chief Legal Officer
See More Headlines

TBIO Stock Analysis - Frequently Asked Questions

Telesis Bio's stock was trading at $0.40 at the start of the year. Since then, TBIO stock has decreased by 25.0% and is now trading at $0.30.

Telesis Bio, Inc. (NASDAQ:TBIO) announced its earnings results on Monday, November, 8th. The company reported ($6.12) earnings per share for the quarter, missing analysts' consensus estimates of ($5.04) by $1.08. The company earned $2.79 million during the quarter, compared to analyst estimates of $2.93 million.

Shares of Telesis Bio reverse split on Thursday, May 9th 2024.The 1-18 reverse split was announced on Thursday, May 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 9th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Telesis Bio (TBIO) raised $100 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 7,700,000 shares at $12.00-$14.00 per share. Citigroup, Leerink Partners and Evercore ISI served as the underwriters for the IPO.

Shares of TBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Telesis Bio investors own include Ford Motor (F), Pfizer (PFE), PayPal (PYPL), SoFi Technologies (SOFI), Plug Power (PLUG) and XPeng (XPEV).

Company Calendar

Last Earnings
11/08/2021
Today
7/04/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:TBIO
Previous Symbol
NASDAQ:DNAY
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.72 million
Net Margins
-336.59%
Pretax Margin
-334.81%

Debt

Sales & Book Value

Annual Sales
$225.09 million
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
2.14

Miscellaneous

Free Float
1,360,000
Market Cap
$540.60 thousand
Optionable
Optionable
Beta
0.96
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:TBIO) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners